KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Cash from Investing Activities (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Cash from Investing Activities for 7 consecutive years, with -$847.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 67.69% to -$847.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.6 billion through Dec 2025, up 39.73% year-over-year, with the annual reading at -$1.6 billion for FY2025, 39.73% up from the prior year.
  • Cash from Investing Activities hit -$847.8 million in Q4 2025 for Royalty Pharma, up from -$958.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $503.9 million in Q1 2025 to a low of -$1.4 billion in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$463.2 million across 5 years, with a median of -$528.6 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 5102.47% in 2023 and later surged 681.55% in 2025.
  • Year by year, Cash from Investing Activities stood at -$551.6 million in 2021, then surged by 175.18% to $414.7 million in 2022, then tumbled by 341.16% to -$1.0 billion in 2023, then soared by 49.45% to -$505.6 million in 2024, then crashed by 67.69% to -$847.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RPRX at -$847.8 million in Q4 2025, -$958.3 million in Q3 2025, and -$312.0 million in Q2 2025.